AMGEN INC Quarterly Operating Income (Loss) in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Amgen Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q2 2024.
  • Amgen Inc Operating Income (Loss) for the quarter ending June 30, 2024 was $1.91B, a 28.9% decline year-over-year.
  • Amgen Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was $6.19B, a 34.8% decline year-over-year.
  • Amgen Inc annual Operating Income (Loss) for 2023 was $7.9B, a 17.4% decline from 2022.
  • Amgen Inc annual Operating Income (Loss) for 2022 was $9.57B, a 25.2% increase from 2021.
  • Amgen Inc annual Operating Income (Loss) for 2021 was $7.64B, a 16.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $6.19B $1.91B -$775M -28.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $6.97B $991M -$930M -48.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $7.9B $1.27B -$959M -43% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-14
Q3 2023 $8.86B $2.02B -$639M -24% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $9.5B $2.68B +$508M +23.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $8.99B $1.92B -$579M -23.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $9.57B $2.23B -$74M -3.21% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 $9.64B $2.66B +$282M +11.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $9.36B $2.18B +$1.35B +163% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $8.01B $2.5B +$371M +17.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $7.64B $2.3B +$296M +14.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 $7.34B $2.38B -$75M -3.06% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $7.42B $828M -$1.5B -64.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $8.91B $2.13B -$226M -9.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $9.14B $2.01B -$40M -1.95% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-09
Q3 2020 $9.18B $2.45B -$23M -0.93% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $9.2B $2.32B -$355M -13.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $9.56B $2.36B -$117M -4.73% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q4 2019 $9.67B $2.05B -$334M -14% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-16
Q3 2019 $10B $2.48B +$153M +6.59% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $9.86B $2.68B -$154M -5.44% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $10B $2.47B -$254M -9.32% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $10.3B $2.38B +$137M +6.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-09
Q3 2018 $10.1B $2.32B -$116M -4.76% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $10.2B $2.83B +$134M +4.97% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $10.1B $2.73B +$135M +5.21% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $9.97B $2.25B -$240M -9.66% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-12
Q3 2017 $10.2B $2.44B -$88M -3.48% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $10.3B $2.7B +$318M +13.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-27
Q1 2017 $9.98B $2.59B +$189M +7.87% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-25
Q4 2016 $9.79B $2.49B +$452M +22.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-13
Q3 2016 $9.34B $2.53B +$188M +8.04% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-26
Q2 2016 $9.15B $2.38B +$304M +14.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-26
Q1 2016 $8.85B $2.4B +$380M +18.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-27
Q4 2015 $8.47B $2.03B +$574M +39.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-13
Q3 2015 $7.9B $2.34B +$873M +59.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 $7.02B $2.08B +$174M +9.15% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q1 2015 $6.85B $2.02B +$658M +48.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $6.19B $1.46B +$272M +22.9% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-14
Q3 2014 $5.92B $1.47B -$222M -13.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $6.14B $1.9B +$352M +22.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $5.79B $1.36B -$78M -5.41% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-27
Q4 2013 $5.87B $1.19B +$99M +9.1% Oct 1, 2013 Dec 31, 2013 8-K 2016-10-31
Q3 2013 $5.77B $1.69B +$265M +18.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-29
Q2 2013 $5.5B $1.55B -$39M -2.45% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $5.54B $1.44B -$35M -2.37% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-30
Q4 2012 $5.58B $1.09B -$74M -6.37% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-19
Q3 2012 $5.65B $1.42B +$898M +171% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-29
Q2 2012 $4.75B $1.59B +$257M +19.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $4.5B $1.48B +$184M +14.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q4 2011 $4.31B $1.16B +$94M +8.8% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-24
Q3 2011 $4.22B $525M -$954M -64.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $5.17B $1.33B -$185M -12.2% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 $5.36B $1.29B -$188M -12.7% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q4 2010 $5.55B $1.07B Oct 1, 2010 Dec 31, 2010 10-K 2013-02-27
Q3 2010 $1.48B Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $1.52B Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 $1.48B Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.